Imatinib: a review of its use in chronic myeloid leukaemia
MD Moen, K McKeage, GL Plosker, MAA Siddiqui - Drugs, 2007 - Springer
Summary Abstract Imatinib (Gleevec®, Glivec®) is a synthetic tyrosine kinase inhibitor used
in the treatment of chronic myeloid leukaemia (CML). It is specifically designed to inhibit the …
in the treatment of chronic myeloid leukaemia (CML). It is specifically designed to inhibit the …
[引用][C] Imatinib: A review of its use in chronic myeloid Leukaemia
MD MOEN, K MCKEAGE, GL PLOSKER… - Drugs …, 2007 - pascal-francis.inist.fr
Imatinib : A review of its use in chronic myeloid Leukaemia CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search …
Imatinib: A Review of its Use in Chronic Myeloid Leukaemia.
MD Moen, K McKeage, GL Plosker, MAA Siddiqui - Drugs, 2007 - search.ebscohost.com
Abstract Imatinib (Gleevec, Glivec) is a synthetic tyrosine kinase inhibitor used in the
treatment of chronic myeloid leukaemia (CML). It is specifically designed to inhibit the …
treatment of chronic myeloid leukaemia (CML). It is specifically designed to inhibit the …
[引用][C] Imatinib
MD Moen, K McKeage, GL Plosker, MAA Siddiqui - Drugs, 2007 - cir.nii.ac.jp
Imatinib | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索
フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文をさがす English …
フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文をさがす English …
Imatinib: a review of its use in chronic myeloid leukaemia
MD Moen, K McKeage, GL Plosker, MAA Siddiqui - Drugs, 2007 - pubmed.ncbi.nlm.nih.gov
Imatinib (Gleevec, Glivec) is a synthetic tyrosine kinase inhibitor used in the treatment of
chronic myeloid leukaemia (CML). It is specifically designed to inhibit the breakpoint cluster …
chronic myeloid leukaemia (CML). It is specifically designed to inhibit the breakpoint cluster …
Imatinib: a review of its use in chronic myeloid leukaemia.
MD Moen, K McKeage, GL Plosker, MA Siddiqui - Drugs, 2007 - europepmc.org
Imatinib (Gleevec, Glivec) is a synthetic tyrosine kinase inhibitor used in the treatment of
chronic myeloid leukaemia (CML). It is specifically designed to inhibit the breakpoint cluster …
chronic myeloid leukaemia (CML). It is specifically designed to inhibit the breakpoint cluster …
Imatinib: a review of its use in chronic myeloid leukaemia
MD Moen, K McKeage, GL Plosker, MAA Siddiqui - Drugs, 2007 - go.gale.com
Imatinib (Gleevec [R], Glivec [R]) is a synthetic tyrosine kinase inhibitor used in the treatment
of chronic myeloid leukaemia (CML). It is specifically designed to inhibit the breakpoint …
of chronic myeloid leukaemia (CML). It is specifically designed to inhibit the breakpoint …